AMY BLANCKE: Open Payments
NPI 1538729421 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,382 in 61 payments from 14 companies in 2025. Trend: 2023 $3,049 · 2024 $2,355 · 2025 $1,382
Food & beverage: $1,382
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $195 |
| Merck Sharp & Dohme LLC | 8 | $180 |
| Novartis Pharmaceuticals Corporation | 7 | $171 |
| GlaxoSmithKline, LLC. | 4 | $167 |
| E.R. Squibb & Sons, L.L.C. | 4 | $150 |
| Amgen Inc. | 8 | $142 |
| Inspire Medical Systems, Inc. | 4 | $96 |
| Alnylam Pharmaceuticals Inc. | 4 | $90 |
| Boston Scientific Corporation | 2 | $57 |
| SCPHARMACEUTICALS INC. | 3 | $56 |
Products named: LEQVIO, VYNDAQEL, VERQUVO, CAMZYOS, REPATHA, AREXVY, INSPIRE, WATCHMAN FLX.
Industry payments across TX — which companies pay providers there.
